Log In Get Started
Press Releases May 8, 2026 09:00 AM

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

Embecta Corp. to Present at 2026 BofA Securities Global Health Care Conference

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
EMBC

Embecta Corp., a global medical supplies company focused on insulin delivery innovations, announced its upcoming presentation at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026. The company's management will discuss its current initiatives and future outlook, with a live webcast available for investors.

embecta to Participate at the 2026 BofA Securities Global Health Care Conference
EMBC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Embecta will present at a major healthcare industry conference, signaling active investor engagement.
  • The company maintains a century-long legacy in insulin delivery, expanding as a broad-based medical supplies provider.
  • Embedded within a global medical supplies and healthcare context, the presentation may highlight innovation and partnerships in diabetes care technology.

PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.

Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.

About embecta 
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

MediaInvestorsChristian GlazarPravesh KhandelwalSr. Director, Corporate CommunicationsVP, Head of Investor Relations908-821-6922551-264-6547Contact Media RelationsContact IR



Risks

  • Market and investor reaction may be limited if no new significant information or guidance is provided at the conference.
  • Competition within the medical supplies and diabetes care market could impact Embecta's growth potential.
  • Healthcare sector regulatory changes or reimbursement challenges may affect company performance and investor sentiment.

More from Press Releases

Skyworks Si829x Isolated Safety Gate Driver Qualified and Ready for Customer Evaluation Oct 7, 2026 Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040 Oct 7, 2026 WillScot Elects Donald Slager to Board of Directors Oct 7, 2026 Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants Oct 7, 2026 Virtu Financial to Host Conference Call Announcing Third Quarter 2026 Results on Thursday, November 5, 2026 Oct 7, 2026